Our goal during the next funding period is to concentrate on the important role that CNS excitatory amino acids (EAAs) have in the control of breathing. This goal will be pursued by: (1) determining the respiratory effects of pharmacologically interfering with CNS EAA neurotransmission by systemic administration of drugs that block NMDA receptors, block the glycine-site NMDA receptor, block non-NMDA receptors, and block the release of glutamate; (2) determine the CNS site of action whereby systemically administered EAA antagonists act to disrupt respiratory activity; and (3) study the effect of EAA antagonists, and other drugs that alter EAA neurotransmission on individual neurons within the ventrolateral subnucleus of the tractus solitarius (VLNTS. The experimental approaches that will be used for these studies include monitoring phrenic nerve activity in decerebrate, vagotomized, and paralyzed animals during drug administration; microinjecting drugs into specific brain sites, particularly into the VLNTS while monitoring phrenic nerve activity; lesioning the VLNTS and evaluating IV administered drugs for phrenic nerve effects under this condition; unit recording of VLNTS neurons in vivo and noting effects of drugs iontopheresed onto these neurons; and using the whole cell patch- clamp recording of single VLNTS neurons in the in vitro brain slice preparation (rat) to study the role of EAAs. In addition, our plan is to use immunohistochemical techniques involving antibodies to specific subtypes of EAA receptors to elucidate which EAA receptors are present on respiratory (inspiratory) neurons. Data obtained from these studies should provide new information on the role of CNS EAAs in controlling breathing. Our data should also provide new insights on how the CNS regulates respiratory activity. Finally, our findings will advance current knowledge on the safety of using EAA antagonists to treat CNS disorders, and may provide a basis for preventing potential deleterious effects of these agents on the respiratory system.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1996
Total Cost
Indirect Cost
Wrathall, Jean R; Emch, Gregory S (2006) Effect of injury severity on lower urinary tract function after experimental spinal cord injury. Prog Brain Res 152:117-34
Teng, Yang Dong; Bingaman, Marian; Taveira-DaSilva, Angelo M et al. (2003) Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats. J Neurosci 23:4182-9
Wasserman, Adam M; Ferreira Jr, Manuel; Sahibzada, Niaz et al. (2002) GABA-mediated neurotransmission in the ventrolateral NTS plays a role in respiratory regulation in the rat. Am J Physiol Regul Integr Comp Physiol 283:R1423-41
Wasserman, A M; Sahibzada, N; Hernandez, Y M et al. (2000) Specific subnuclei of the nucleus tractus solitarius play a role in determining the duration of inspiration in the rat. Brain Res 880:118-30
Grossman, S D; Wolfe, B B; Yasuda, R P et al. (2000) Changes in NMDA receptor subunit expression in response to contusive spinal cord injury. J Neurochem 75:174-84
Sahibzada, N; Ferreira, M; Wasserman, A M et al. (2000) Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. J Pharmacol Exp Ther 292:704-13
Doherty, J; Gale, K; Eagles, D A (2000) Evoked epileptiform discharges in the rat anterior piriform cortex: generation and local propagation. Brain Res 861:77-87
Masco, D; Sahibzada, N; Switzer, R et al. (1999) Electroshock seizures protect against apoptotic hippocampal cell death induced by adrenalectomy. Neuroscience 91:1315-9
Kozikowski, A P; Araldi, G L; Tuckmantel, W et al. (1999) 1-amino-APDC, a partial agonist of group II metabotropic glutamate receptors with neuroprotective properties. Bioorg Med Chem Lett 9:1721-6
Dunah, A W; Yasuda, R P; Luo, J et al. (1999) Biochemical studies of the structure and function of the N-methyl-D-aspartate subtype of glutamate receptors. Mol Neurobiol 19:151-79

Showing the most recent 10 out of 108 publications